Sharps Compliance (NASDAQ:SMED) Rating Lowered to Sell at Zacks Investment Research

Sharps Compliance (NASDAQ:SMEDGet Rating) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a research note issued to investors on Wednesday, Zacks.com reports.

According to Zacks, “Headquartered in Houston, Texas, SHARPS COMPLIANCE is a leading provider of cost-effective disposal solutions for small quantity generators of medical waste. The Company’s flagship product, the Sharps Disposal by Mail System, is a cost-effective and easy-to-use solution to dispose of medical waste such as hypodermic needles, lancets and any other medical device or objects used to puncture or lacerate the skin. The Company also offers a number of products specifically designed for the home healthcare market. Sharps Compliance focuses on targeted growth markets such as the pharmaceutical, retail, healthcare, commercial, professional and hospitality markets, as well as serving a variety of additional markets. Sharps is a leading proponent and participant in the development of public awareness and solutions for the safe disposal of needles, syringes and other sharps in the community setting. “

Several other research analysts also recently weighed in on SMED. Roth Capital downgraded shares of Sharps Compliance from a “buy” rating to a “neutral” rating and lowered their price objective for the stock from $12.00 to $7.00 in a report on Tuesday, April 5th. StockNews.com began coverage on shares of Sharps Compliance in a research report on Thursday, March 31st. They set a “hold” rating for the company. One research analyst has rated the stock with a sell rating and four have given a hold rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average price target of $12.88.

Shares of Sharps Compliance stock opened at $4.75 on Wednesday. The business has a 50-day simple moving average of $5.72 and a 200 day simple moving average of $6.80. Sharps Compliance has a one year low of $4.71 and a one year high of $18.67. The company has a debt-to-equity ratio of 0.06, a current ratio of 3.85 and a quick ratio of 3.40. The firm has a market capitalization of $91.42 million, a price-to-earnings ratio of 6.60 and a beta of -0.22.

Sharps Compliance (NASDAQ:SMEDGet Rating) last released its quarterly earnings data on Wednesday, January 26th. The industrial products company reported $0.07 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $0.08 by ($0.01). Sharps Compliance had a net margin of 15.91% and a return on equity of 19.50%. The firm had revenue of $18.88 million for the quarter, compared to the consensus estimate of $18.41 million. During the same quarter in the prior year, the firm earned $0.07 EPS. On average, sell-side analysts expect that Sharps Compliance will post 0.12 EPS for the current year.

A number of institutional investors and hedge funds have recently bought and sold shares of the business. Citigroup Inc. grew its stake in shares of Sharps Compliance by 228.8% in the 4th quarter. Citigroup Inc. now owns 5,544 shares of the industrial products company’s stock worth $40,000 after acquiring an additional 3,858 shares in the last quarter. Royal Bank of Canada grew its position in Sharps Compliance by 552.0% in the 3rd quarter. Royal Bank of Canada now owns 7,804 shares of the industrial products company’s stock worth $65,000 after purchasing an additional 6,607 shares in the last quarter. California State Teachers Retirement System grew its position in Sharps Compliance by 32.0% in the 4th quarter. California State Teachers Retirement System now owns 10,133 shares of the industrial products company’s stock worth $72,000 after purchasing an additional 2,454 shares in the last quarter. HighVista Strategies LLC purchased a new stake in Sharps Compliance in the 3rd quarter valued at about $92,000. Finally, Janney Montgomery Scott LLC bought a new position in shares of Sharps Compliance during the 3rd quarter worth approximately $110,000. 54.72% of the stock is currently owned by hedge funds and other institutional investors.

Sharps Compliance Company Profile (Get Rating)

Sharps Compliance Corp. provides medical, pharmaceutical, and hazardous waste management services in the United States. It offers Sharps Recovery System for the containment, transportation, treatment, and tracking of medical waste generated outside the hospital and health care facility settings; TakeAway Recovery System to treat used needles, syringes, and other used healthcare products; Route-Based Pickup Service, a medical and hazardous waste pick-up services; and MedSafe, a solution for the safe collection, transportation, and disposal of unwanted and expired ultimate-user medications.

Featured Articles

Get a free copy of the Zacks research report on Sharps Compliance (SMED)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Sharps Compliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sharps Compliance and related companies with MarketBeat.com's FREE daily email newsletter.